Tesamorelin
Analogue de la GHRH approuvé par la FDA pour la lipodystrophie associée au VIH
Aperçu
Tesamorelin est un analogue de la GHRH approuvé par la FDA, spécifiquement indiqué pour le traitement de la lipodystrophie associée au VIH (excès de graisse abdominale).
Key Information
Mechanism
Analogue stabilisé de la GHRH qui stimule la production endogène de GH, ciblant la réduction de la graisse viscérale.
Benefits
- Approuvé par la FDA
- Réduit la graisse viscérale
- Cible la lipodystrophie liée au VIH
- Stimule la GH naturelle
Side Effects
- Réactions au site d'injection
- Douleurs articulaires
- Œdème léger
Contraindications
- Active cancer
- Pregnancy
- Disruption of hypothalamic-pituitary axis
Evidence Summary
Approuvé par la FDA sur la base d'essais de phase 3 démontrant une réduction du tissu adipeux viscéral dans la lipodystrophie liée au VIH.
Research
Approuvé par la FDA sur la base d'essais de phase 3 montrant une réduction significative du tissu adipeux viscéral.
View ResearchSafety
Approuvé par la FDA. Les effets secondaires comprennent des réactions au site d'injection et des douleurs articulaires.
Frequently Asked Questions About Tesamorelin
What is Tesamorelin?
Tesamorelin is a research peptide also known as Egrifta. Analogue de la GHRH approuvé par la FDA pour la lipodystrophie associée au VIH It is studied for its potential therapeutic applications and is available from various research chemical vendors.
How does Tesamorelin work?
Analogue stabilisé de la GHRH qui stimule la production endogène de GH, ciblant la réduction de la graisse viscérale.
What is the recommended dosage for Tesamorelin?
The commonly studied dosage range for Tesamorelin is 2 mg daily. Dosage protocols vary based on research objectives. Always consult published studies and start with conservative amounts. Tesamorelin should only be used in controlled research settings.
Where can I buy Tesamorelin?
PepsReview indexes Tesamorelin pricing from multiple vendors. Check the Vendors tab above for a price comparison table showing cost per milligram, purity, COA status, and stock availability. Vendor reviews from real users are available on each vendor's profile page.
Is Tesamorelin legal?
US regulatory status: FDA-approved (Egrifta). The legal status of Tesamorelin varies by jurisdiction. In most countries, it is sold as a research chemical, not for human consumption. Always verify the legal status in your country before purchasing.
What are the side effects of Tesamorelin?
Reported side effects include: Réactions au site d'injection, Douleurs articulaires, Œdème léger. Always review safety data and published studies before use.
Key Research Papers on Tesamorelin
The following peer-reviewed studies and clinical trials are indexed in our research library for Tesamorelin. Each paper links to a detailed summary with key findings, study design, and publication metadata.
- Tesamorelin: a review of its use in the management of HIV-associated lipodystrophy — Drugs, 2011 (300 citations)
- Spotlight on tesamorelin in HIV-associated lipodystrophy — BioDrugs, 2011 (300 citations)
- Tesamorelin: a growth hormone-releasing factor analogue for HIV-associated lipodystrophy — Ann Pharmacother, 2012 (280 citations)
Related Growth hormone boosters Peptides
Other peptides in the growth hormone boosters category that may be of interest for comparative research:
Write a Review
Rating Breakdown
Based on 2 avis.
Avis
Tesamorelin specifically targets visceral fat. Lost 3 inches off waist in 4 months. FDA-approved for HIV lipodystrophy but works for metabolic syndrome too. GH stimulation is natural and potent.
Tesamorelin works well for visceral fat reduction but the cost is very high. Better results than CJC-1295 for abdominal fat. If you can afford it and have stubborn visceral fat, this is the peptide.